SUBSCRIBE
SUBSCRIBE
News   Policy

Roche Says Still Discussing Actemra with FDA

October 21, 2008 | 
1 min read
ZURICH, Oct 21 (Reuters) - Roche Holding AG is still discussing what additional information is required for approval of its Actemra rheumatoid arthritis drug with U.S. regulators, the Swiss company said on Tuesday.
Regulatory Europe
Food and Drug Administration (FDA) Roche
MORE ON THIS TOPIC
FDA Commissioner Dr. Marty Makary delivers remarks after President Donald Trump made an announcement on drug pricing, Tuesday, September 30, 2025, in the Oval Office. (Official White House Photo by Joyce N. Boghosian)
Government
Signs of Frustration Build Between Kennedy and FDA Commissioner Makary
November 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Pfizer Wins Metsera, Trump Strikes GLP-1 Pricing Deal, FDA Awards More Priority Vouchers
November 12, 2025
 · 
1 min read
 · 
Heather McKenzie
Silver Spring, MD, USA 11/10/2020: Exterior view of the headquarters of US Food and Drug Administration (FDA). This federal agency approves medications, vaccines and food additives for human use.
FDA
FDA Stalwart Pazdur Named Tidmarsh’s Replacement as CDER Director
November 11, 2025
 · 
1 min read
 · 
Heather McKenzie
factory of the pharmaceutical industry. pills on the conveyor
Manufacturing
Drugmakers Push FDA To Extend Support to Existing Facilities
November 11, 2025
 · 
4 min read
 · 
Nick Paul Taylor